Ironwood Pharmaceuticals (IRWD) Current Leases (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Current Leases across 17 years of filings, most recently posting $3.3 million for Q2 2026.

• In Q2 2026, Current Leases rose 2.02% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at $3.3 million (up 2.02% YoY), while the FY2025 annual figure was $3.3 million, up 1.98% from the prior year.
• Current Leases came in at $3.3 million for Q2 2026 at Ironwood Pharmaceuticals, up from $3.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.3 million in Q2 2026 to a low of $3.0 million in Q3 2022.
• Average Current Leases over 5 years is $3.2 million, with a median of $3.1 million recorded in 2024.
• Year-over-year, Current Leases decreased 3.39% in 2022 and increased 2.02% in 2026.
• Over 5 years, Current Leases stood at $3.1 million in 2022, then gained by 1.99% to $3.1 million in 2023, then climbed by 2.02% to $3.2 million in 2024, then advanced by 1.98% to $3.3 million in 2025, then grew by 1.01% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $3.3 million in Q2 2026, $3.3 million in Q1 2026, and $3.3 million in Q4 2025.